Stock & Company Details
Harrow Health Inc $HROW
Price:
N/A
N/A
37M
$1.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
-74.64
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
HROW technical indicators
Latest Harrow Health Inc (HROW) indicator readings as of 2026-10-09.
HROW's 14-day RSI is 24.3, in oversold territory. At $29.36 it is trading 26.5% below its 200-day moving average of $39.95, and below its 50-day average of $36.29. Price sits near the lower Bollinger Band ($28.94 to $35.34). ADX reads 40.4, indicating a trending market.
Overview
Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics, and Melt Pharmaceuticals. The Company also owns royalty rights in four clinical-stage drug candidates being developed by Surface and Melt. Supported by dedicated employees, Harrow intends to create, invest in and grow paradigm shifting healthcare businesses that put patients first.
Finance Bot
Ask your questions
Start by typing a question below.
